feed,title,long_url,short_url
SeekingAlpha,Incyte ending phase 3 program evaluating myelofibrosis candidate parsaclisib,https://seekingalpha.com/news/3944167,
SeekingAlpha,"Tapinator GAAP EPS of -$0.22, revenue of $1.15B",https://seekingalpha.com/news/3944165,
